@article{c8a2b0e2eb3f48748122716db9044375,
title = "The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances",
keywords = "Adult, Amino Acid Sequence, Antibodies, Neutralizing/blood, Antibodies, Viral/blood, COVID-19 Vaccines/immunology, COVID-19/immunology, Female, Humans, Immunization, Secondary, Male, Middle Aged, SARS-CoV-2/immunology, Spike Glycoprotein, Coronavirus/immunology, United States/epidemiology",
author = "Fei Heng and Magaret, \{Craig A.\} and Rouphael, \{Nadine G.\} and Branche, \{Angela R.\} and Youyi Fong and Carpp, \{Lindsay N.\} and Chenchen Yu and Shiyu Chen and Bo Zhang and Diemert, \{David J.\}",
note = "Copyright {\textcopyright} 2026 The Authors. Published by Elsevier Ltd.. All rights reserved.",
year = "2026",
month = feb,
day = "19",
doi = "10.1016/j.vaccine.2026.128348",
language = "English",
volume = "76",
pages = "128348",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier",
}